Together, these findings establish GPR68 as a tractable proton-sensing inflammatory node that links tissue acidification to metabolic liver injury and highlight GPR68 as a promising therapeutic strategy for MASH. Here, GPR68 is linked to metabolic dysfunction-associated steatohepatitis.